fixed-duration treatment strategies for frontline and relapsed cll
Published 1 year ago • 165 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
12:46
fixed duration treatment strategies in cll
-
1:32
cll14: feasibility of fixed-duration frontline therapy in cll
-
2:51
the optimum approach to frontline treatment of cll in 2021
-
2:41
fixed-duration vs continuous therapy in cll
-
1:09
current and emerging treatment strategies for cll & defining the optimal treatment duration
-
7:24
what are the current cll treatment options?
-
7:29
what cll tests are essential and how do results impact treatment and prognosis?
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:56
the future of fixed-duration therapy in cll
-
1:27
factors to consider in frontline and relapsed cll before treatment
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
0:57
unanswered questions in frontline cll treatment
-
1:54
treatment strategies for recurrent cll
-
4:05
comparing continuous and fixed duration therapy in cll
-
2:19
long-term management of cll for improved outcomes
-
1:22
shortening the duration of treatment with fixed-duration or mrd-adapted regimens in cll
-
1:38
front-line use of ibrutinib for cll in a real-world setting
-
0:53
the future of cll treatment
-
3:02
tailored treatment strategies for cll
-
12:15
challenges of selecting frontline therapy in cll
-
1:29
the importance of treatment sequencing in cll